Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location or be switched to your location?
Multicolor flow cytometric analysis of CD4 expression on mouse splenocytes. Splenic leukocytes were stained simultaneously with PE Hamster Anti-Mouse CD3e antibody (Cat. No. 561824/553063/553064) and with either BD Pharmingen™ FITC Rat IgG2a, κ Isotype Control (Cat. No. 553988; Left Panel) or BD Pharmingen™ FITC Rat Anti-Mouse CD4 antibody (Cat. No. 553729; Right Panel). Two-color flow cytometric dot plots show the correlated expression patterns of CD4 (or Ig Isotype control staining) versus CD3 for gated events with the forward and side light-scatter characteristics of viable splenic leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD4 expression on mouse splenocytes. Splenic leukocytes were stained simultaneously with PE Hamster Anti-Mouse CD3e antibody (Cat. No. 561824/553063/553064) and with either BD Pharmingen™ FITC Rat IgG2a, κ Isotype Control (Cat. No. 553988; Left Panel) or BD Pharmingen™ FITC Rat Anti-Mouse CD4 antibody (Cat. No. 553729; Right Panel). Two-color flow cytometric dot plots show the correlated expression patterns of CD4 (or Ig Isotype control staining) versus CD3 for gated events with the forward and side light-scatter characteristics of viable splenic leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD4 expression on mouse splenocytes. Splenic leukocytes were stained simultaneously with PE Hamster Anti-Mouse CD3e antibody (Cat. No. 561824/553063/553064) and with either BD Pharmingen™ FITC Rat IgG2a, κ Isotype Control (Cat. No. 553988; Left Panel) or BD Pharmingen™ FITC Rat Anti-Mouse CD4 antibody (Cat. No. 553729; Right Panel). Two-color flow cytometric dot plots show the correlated expression patterns of CD4 (or Ig Isotype control staining) versus CD3 for gated events with the forward and side light-scatter characteristics of viable splenic leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD4 expression on mouse splenocytes. Splenic leukocytes were stained simultaneously with PE Hamster Anti-Mouse CD3e antibody (Cat. No. 561824/553063/553064) and with either BD Pharmingen™ FITC Rat IgG2a, κ Isotype Control (Cat. No. 553988; Left Panel) or BD Pharmingen™ FITC Rat Anti-Mouse CD4 antibody (Cat. No. 553729; Right Panel). Two-color flow cytometric dot plots show the correlated expression patterns of CD4 (or Ig Isotype control staining) versus CD3 for gated events with the forward and side light-scatter characteristics of viable splenic leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD4 expression on mouse splenocytes. Splenic leukocytes were stained simultaneously with PE Hamster Anti-Mouse CD3e antibody (Cat. No. 561824/553063/553064) and with either BD Pharmingen™ FITC Rat IgG2a, κ Isotype Control (Cat. No. 553988; Left Panel) or BD Pharmingen™ FITC Rat Anti-Mouse CD4 antibody (Cat. No. 553729; Right Panel). Two-color flow cytometric dot plots show the correlated expression patterns of CD4 (or Ig Isotype control staining) versus CD3 for gated events with the forward and side light-scatter characteristics of viable splenic leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of CD4 expression on mouse splenocytes. Splenic leukocytes were stained simultaneously with PE Hamster Anti-Mouse CD3e antibody (Cat. No. 561824/553063/553064) and with either BD Pharmingen™ FITC Rat IgG2a, κ Isotype Control (Cat. No. 553988; Left Panel) or BD Pharmingen™ FITC Rat Anti-Mouse CD4 antibody (Cat. No. 553729; Right Panel). Two-color flow cytometric dot plots show the correlated expression patterns of CD4 (or Ig Isotype control staining) versus CD3 for gated events with the forward and side light-scatter characteristics of viable splenic leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Becton, Dickinson and Company의 명시적인 서면 승인 없이는 사용 하실 수 없습니다.
The GK1.5 monoclonal antibody specifically binds to the mouse CD4 (L3T4) differentiation antigen. CD4 is expressed on most thymocytes, a subpopulation of mature T lymphocytes (i.e., MHC class II-restricted T cells, including most T helper cells), and a subset of NK-T cells. In addition, CD4 has also been reported to be detectable on pluripotent hematopoietic stem cells, bone marrow myeloid and B-lymphocyte precursors, intrathymic lymphoid precursors, and a subset of splenic dendritic cells. CD4 has also been reported to be expressed on the plasma membrane of mouse egg cells and is involved in adhesion of the egg to MHC class II-bearing sperm. CD4 is an antigen coreceptor on the T-cell surface which interacts with MHC class II molecules on antigen-presenting cells. It participates in T-cell activation through its association with the T-cell receptor complex and protein tyrosine kinase lck. The GK1.5 antibody reportedly blocks binding of the RM4-5 and H129.19, but not RM4-4 mouse CD4-specific antibodies.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.